Search research articles
Contact Us
Filters
Showing results (1-10 of 102) with videos related to
Page
of 11
Sort By:
Expert Opinion on Therapeutic Patents
|
June 18, 2011
Translational research on prolyl oligopeptidase inhibitors: the long road ahead
Anne-Marie Lambeir
CNS & Neurological Disorders Drug Targets
|
January 13, 2011
Interaction of prolyl oligopeptidase with α-synuclein
Anne-Marie Lambeir
CNS & Neurological Disorders Drug Targets
|
January 13, 2011
Structure and function relationship in prolyl oligopeptidase
Roos Van Elzen, Anne-Marie Lambeir
Expert Opinion on Therapeutic Targets
|
January 9, 2013
The potential of carboxypeptidase M as a therapeutic target in cancer
Catherine J Denis, Anne-Marie Lambeir
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
October 13, 2006
Suggested functions for prolyl oligopeptidase: a puzzling paradox
Inger Brandt, Simon Scharpé, Anne-Marie Lambeir
Biochemical Pharmacology
|
August 30, 2008
DPP4 inhibitors for diabetes--what next?
Anne-Marie Lambeir, Simon Scharpé, Ingrid De Meester
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
October 30, 2008
Carboxypeptidase M: Multiple alliances and unknown partners
Kathleen Deiteren, Dirk Hendriks, Simon Scharpé, et al.
Biochemistry
|
December 27, 2002
The catalytic cycle of biosynthetic thiolase: a conformational journey of an acetyl group through four binding modes and two oxyanion holes
Petri Kursula, Juha Ojala, Anne-Marie Lambeir, et al.
Biochemical Pharmacology
|
November 26, 2002
A kinetic study of glucagon-like peptide-1 and glucagon-like peptide-2 truncation by dipeptidyl peptidase IV, in vitro
Anne-Marie Lambeir, Paul Proost, Simon Scharpé, et al.
Critical Reviews in Clinical Laboratory Sciences
|
August 2, 2003
Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV
Anne-Marie Lambeir, Christine Durinx, Simon Scharpé, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 102) with videos related to
Sort By:
Page
of 11
Expert Opinion on Therapeutic Patents
|
June 18, 2011
Translational research on prolyl oligopeptidase inhibitors: the long road ahead
Anne-Marie Lambeir
CNS & Neurological Disorders Drug Targets
|
January 13, 2011
Interaction of prolyl oligopeptidase with α-synuclein
Anne-Marie Lambeir
CNS & Neurological Disorders Drug Targets
|
January 13, 2011
Structure and function relationship in prolyl oligopeptidase
Roos Van Elzen, Anne-Marie Lambeir
Expert Opinion on Therapeutic Targets
|
January 9, 2013
The potential of carboxypeptidase M as a therapeutic target in cancer
Catherine J Denis, Anne-Marie Lambeir
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
October 13, 2006
Suggested functions for prolyl oligopeptidase: a puzzling paradox
Inger Brandt, Simon Scharpé, Anne-Marie Lambeir
Biochemical Pharmacology
|
August 30, 2008
DPP4 inhibitors for diabetes--what next?
Anne-Marie Lambeir, Simon Scharpé, Ingrid De Meester
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
October 30, 2008
Carboxypeptidase M: Multiple alliances and unknown partners
Kathleen Deiteren, Dirk Hendriks, Simon Scharpé, et al.
Biochemistry
|
December 27, 2002
The catalytic cycle of biosynthetic thiolase: a conformational journey of an acetyl group through four binding modes and two oxyanion holes
Petri Kursula, Juha Ojala, Anne-Marie Lambeir, et al.
Biochemical Pharmacology
|
November 26, 2002
A kinetic study of glucagon-like peptide-1 and glucagon-like peptide-2 truncation by dipeptidyl peptidase IV, in vitro
Anne-Marie Lambeir, Paul Proost, Simon Scharpé, et al.
Critical Reviews in Clinical Laboratory Sciences
|
August 2, 2003
Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV
Anne-Marie Lambeir, Christine Durinx, Simon Scharpé, et al.
Page
of 11